Asia Pharma & Lab Expo 2017 showcases latest pharma manufacturing technologies


With 612 exhibiting companies from 29 countries and attended by more than 10,600 trade attendee.

The 9th Asia Pharma Expo 2017 and Asia Lab Expo 2017 – an international exhibition on COMPLETE pharma manufacturing technologies were inaugurated on February 23, 2017 by the Chief Guest Mr. Tofail Ahmed, MP, Hon’ble Minister of Commerce, Govt. of Peoples’ Republic of Bangladesh at Dhaka, Bangladesh.

The growth of the Bangladesh pharmaceutical industry is highly remarkable. After the liberation, Bangladesh used to import at least 70% of medicines against the demand. At present, only 3% of the drugs are being imported while remaining 97% being produced from local manufacturers. Bangladesh is on top position among all the LDCs by manufacturing and exporting highest figures in terms of revenue as well quantity. Bangladesh pharmaceutical industry has got the waiver from WTO to continue manufacturing of the patented medicines till Jan-2033, and this has boosted the annual growth to more than 20% for the Bangladesh pharma sector.

ASIA PHARMA EXPO 2017 and ASIA LAB EXPO 2017 also focuses the pharma, neutraceuticals, cosmetics and biotech manufacturing segments of the Industry.

The exhibiting companies from India, Korea, China, Taiwan, Bangladesh, Singapore, Middle East, European Union, USA exhibited exhaustive wide range of latest pharma manufacturing technologies which include – Pharma Processing & Packaging Machineries & Materials; Analytical / QA – QC / Biotech Laboratories instruments, Glass-wares, Consumables, Reagents; API / Bulk Active / Pharma Ingredients & Raw Masterials; Cleanroom & Water Management Eqpts & Services; Projects & Turn-key Consultants; Trade Publications, etc.

GlaxoSmithKline Agrees to buy Sierra Oncology for $1.9bn
The inaugural ceremony was attended, among the others, Mr. Zahid Maleque – Minister of State, Health & Family Welfare, Govt. of Republic of Bangladesh; Mr. Major General Mustafizur Rahman, Directorate General of Drug Admnistration of Bangladesh; Mr. Salman F. Rahman, Vice Chairman – Baximco Group of Companies; Dr. Momenul Haq, MD, General Pharmaceuticals Ltd. – both Advisor to Bangladesh Association of Pharmaceutical Industries – BAPI (Bangladesh Aushad Shilpa Samity); ; Mr. Harunur Rashid – Sr. Vice President of BAPI & CMD of Globe Pharmaceuticals Ltd., Mr. S. M. Shafiuzzaman, Secretary General – BAPI, Mr. Abdul Muktadir, MD – Incepta Pharmaceuticals Ltd.

“98% of the local drugs demand is being met by the domestic pharma manufacturers. Bangladesh is the largest producer and exporter of the pharma formulations among the LDCs. Bangladesh is self-sufficient in the pharmaceutical sector thanks to the significant progress the industry made in the last three decades. The pharmaceutical sector has now reached such a position that it has made the country proud. The government is ready to provide all kinds of logistics support for the further development of the pharma sector of Bangladesh. Government is also working to reduce the import of raw materials so that the stakeholders can produce good quality medicines.

“The government will go tough on low-quality drug manufacturers to ensure quality of the medicine and fair price in country. The abnormal price hike has become a problem in the country, for which is necessary to control the quality and price of medicines for common people. Stern actions will be taken against those producing substandard medicines.”

Gentry Prescription drugs AV [Sample Demo 1]

“The pharma manufacturing sector of Bangladesh directly contributing to the country’s economic development. Bangladesh is now exporting the pharma finished products to more than 127 countries worldwide. Now we have to look for more foreign destinations to export the medicines.”

“The Bangladesh pharma sector has grown constantly and continues to expand. It has matured in all aspects in terms of quality improvements and overall control of the government. There is a huge demand for medicine in the global markets. At present, Bangladesh earns about USD 82 million from exporting pharma formulations. Entrepreneurs expect that Bangladesh to grab 10% of the global pharma export market in next 10 years.”

Accelerating whooping growth of 20% per annum of the Bangladesh pharmaceutical industry, ASIA PHARMA EXPO 2017 and ASIA LAB EXPO 2017 exhibitions celebrated its highly successful 15 years as the Growth Partner of the Bangladesh pharma industry.

The Exhibition – APE 2017 had remained most resourceful for upcoming 46 new projects on API manufacturing facilities at API Park, near Dhaka; alongside of the ongoing expansions and updations of the existing more than 350 manufacturing facilities of the local pharma companies.

Community Pharmacists Pivotal to Your Success, Oladigbolu Tells Vitabiotics

Special Pavilions were set up at ASIA PHARMA EXPO 2017 by EEPC INDIA (formerly known as Engineering Export Promotion Council of India, set up by Ministry of Commerce, Govt. of India) and ITPO (India Trade Promotion Organization, Govt. of India), where 20 and 50 exhibiting companies respectively participated. The Exhibition was supported by IPMMA (Indian Pharma Machinery Manufacturers’ Association).

The ASIA PHARMA EXPO exhibitions are being jointly organized in Bangladesh by GPE EXPO PVT. LTD. and Bangladesh Aushad Shilpa Samity (Bangladesh Association of Pharmaceutical Industry) since year 2003, and have emerged as the most authenticated source for everything which required for a pharma manufacturing plant. As compared to all previous editions of ASIA PHARMA EXPO, the APE 2017 exhibition responded overwhelmingly by the industry – Bangladesh as well from world over, in terms of companies exhibiting and pharma professionals getting registered well in advance to attend the Exhibition. The next edition – 10th ASIA PHARMA EXPO 2018 will be held during Fberuary 2018 at Dhaka, Bangladesh. The list of the exhibiting companies and more information can be accessed from or email to:


Please enter your comment!
Please enter your name here